Zineh Tapped as FDA's Associate Director for Genomics; ABI Board Members to Resign Following Invitrogen Merger; Mardis Joins Pac Bio's SAB; and Others | GenomeWeb
NEW YORK (GenomeWeb News) - Issam Zineh has joined the US Food and Drug Administration as associate director for genomics in the Office of Clinical Pharmacology, GenomeWeb Daily News has learned. 
 
Zineh was previously associate director of the Pharmacogenomics Center at the University of Florida, where he was also an assistant professor of clinical practice. 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.